These are the things that concern me, and have the whole time. I might be wrong, and I hope I am, but not something I would put money on.
You said similar at 30 cents and that's worked out a real treat for you .... almost akin to you arguing with me that the FDA would never entertain / support an AA pathway for CHF based on the already completed Rexlemestrocel-L trials and yet here we are with pre BLA meeting next month and a BLA submission likely prior to the end of the year .... lol
I would follow Gregory George over you any day Doc - he has circa 3/4 of a billion dollars investment in Mesoblast and probably has a little bit more experience in the medical sector than you ... enjoy your day
MSB Price at posting:
$2.71 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)